Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic Status.
Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic Status.
Yoshihiro Endo, Shinichiro Shinzaki, Katsuyoshi Matsuoka, Shoko Arai et al.
Journal
PubMed
Topics
Inflammatory Bowel Disease
article
Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic Status.
Toho University (JP), Kyorin University (JP), Keio University (JP), Toho University Medical Center Sakura Hospital (JP), Pfizer (Japan) (JP), Hyogo University (JP)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic Status. — Yoshihiro Endo, Shinichiro Shinzaki, et al. · PubMed (2025) | TGRS Research Map | TGRS